BAKER BROS. ADVISORS LP 13D and 13G filings for Idera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-09 5:14 pm Sale |
2021-03-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
BAKER BROS. ADVISORS LP | 245,702 4.900% |
-300,335 (-55.00%) |
Filing |
| 2021-01-29 4:38 pm Sale |
2020-12-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
BAKER BROS. ADVISORS LP | 546,037 12.100% |
-6,446 (-1.17%) |
Filing |